Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
- Rubraca
Descriptions
Rucaparib is used as maintenance treatment in patients with ovarian cancer, fallopian tube cancer, or primary peritoneal cancer that has come back. It is used in patients who have received complete or partial treatment with platinum-based cancer medicines.
Rucaparib is also used to treat ovarian cancer, fallopian tube cancer, or primary peritoneal cancer in patients who have received 2 or more cancer medicines. It is only used in patients who have a certain type of inherited (germline) or acquired (somatic) abnormal BRCA gene. Your doctor will test for the presence of this gene.
Rucaparib is also used to treat metastatic castration-resistant prostate cancer (prostate cancer that has spread and is resistant to medical or surgical treatments that lower testosterone). It is only used in patients who have a certain type of inherited (germline) or acquired (somatic) abnormal BRCA gene. Your doctor will test for the presence of this gene.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: June 01, 2020
Copyright © 2020 IBM Watson Health. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.